FIDALIA.AI · HEALTHCARE AI DATA MOBILITY LAYER

On-demand biological truth for healthcare AI.

No single jurisdiction holds the full picture of human biology. Reach representative global patient populations on demand to build and validate clinical AI.

For Builders: Scope a Cohort →For Data Providers: Become a Data Partner ↗

LIVE COHORT LEDGERPick a clinical frontier. See how isolated silos become one decision-ready cohort—while every patient record stays home.

01 · Isolated Local SilosSTAYS BEHIND FIREWALL

Site A · US Academic Medical Center (HIPAA)

+ Signal: Deep treatment lines & survival follow-up (N=3,400)

− Blind Spot: 89% Caucasian skew; missing Asian EGFR mutation prevalence

Site B · European Thoracic Registry (GDPR)

+ Signal: Standardized staging & serial CT response markers

− Blind Spot: Cross-border export legally blocked; incomplete lab panels

Site C · APAC Tertiary Oncology Network (DPDP / PDPA)

+ Signal: High-density non-Caucasian EGFR/KRAS sub-phenotypes

− Blind Spot: Fragmented outpatient post-discharge follow-up

02 · HALE™ Layer

What Site A lacks, Site B & C supply. Bridges clinical signals across borders with zero record extraction.

SOVEREIGNTY

0 Patient Records Moved

TIME TO COHORT

Days (vs. 3–11 Mo IRB / DUA)

Clinically real. Never identical.

03 · What Your AI Sees97.6% Clinical Fidelity

DELIVERED DIGITAL COHORT

25,000 Decision-Ready Patient Trajectories

5-Year Longitudinal Horizon

✓ Balanced US, EU & APAC biomarker distributions

✓ Complete treatment-to-outcome temporal sequences

✓ Zero patient identity overlap · Auditable provenance

Outcome: Deployed for External Synthetic Control Arm & Global FDA/EMA Bridging

THE AI TRAINING DATA GAP

The world’s patient population is largely invisible to your models.

80% of humanity accounts for less than 5% of accessible clinical training data—locked behind 172+ regulatory regimes. Your AI is only as diverse as the biology it can reach.

Asia Pacific & India

78% → ~5%

Share of population vs. accessible AI training data

Middle East & Africa

21% → <1%

Fastest-growing patient demographics globally

North America & EU

17% → ~85%

Smallest population share · Dominant training source

THE CORE NETWORK THESIS

“No single silo is complete. Together they are more than the sum.”

In isolation, every hospital dataset is locally biased or modality-gapped. Connected through Fidalia, what Site A lacks, Site B supplies—unlocking the complete picture of human biology on demand.

FOR AI BUILDERS & BIOPHARMA

Decision-ready cohorts in weeks, not quarters.

10–20×

ROI vs. failed IRB

Days

Vs. 3–11 mo IRB / DUA

97.3

Clinical fidelity

Validate feasibility, bridge US-to-global populations, and power autonomous health systems without 9-month DUA bottlenecks.

Explore Solutions for Builders (HALE™ + Data Tune) →

FOR HEALTH SYSTEMS & DATA PROVIDERS

Turn dormant archives into recurring Data Dividends.

$0 → ∞

Recurring dividends

100%

Local sovereignty

Zero

Manual SQL drag

Patient records never leave your firewall. Scale beyond your standalone member size by pooling complementary clinical signals globally.

Explore Value for Data Providers →